Collegium to Report Fourth Quarter and Full-Year 2023 Financial Results on February 22, 2024
February 08 2024 - 8:00AM
Collegium Pharmaceutical, Inc. (Nasdaq: COLL), a leading,
diversified specialty pharmaceutical company committed to improving
the lives of people living with serious medical conditions, today
announced that it will report fourth quarter and full-year 2023
financial results after the market closes on Thursday,
February 22, 2024. Following the release of the financials, the
Company will host a live conference call and webcast at 4:30
p.m. ET.
Conference Call
Information To access the conference call, please
dial (877) 407-8037 (U.S.) or (201) 689-8037 (International) and
reference the “Collegium Pharmaceutical Q4 2023 Earnings Call.” An
audio webcast will be accessible from the Investors section of the
Company’s website: www.collegiumpharma.com. The webcast will
be available for replay on the Company’s website approximately two
hours after the event.
About Collegium Pharmaceutical,
Inc.Collegium is a leading, diversified specialty
pharmaceutical company committed to improving the lives of people
living with serious medical conditions. Collegium’s headquarters
are located in Stoughton, Massachusetts. For more information,
please visit the Company’s website at www.collegiumpharma.com.
Investor Contact: Christopher James, M.D.Vice
President, Investor Relationsir@collegiumpharma.com
Media Contact:Marissa SamuelsVice President,
Corporate Communicationscommunications@collegiumpharma.com
Collegium Pharmaceutical (NASDAQ:COLL)
Historical Stock Chart
From Apr 2024 to May 2024
Collegium Pharmaceutical (NASDAQ:COLL)
Historical Stock Chart
From May 2023 to May 2024